Correlation Engine 2.0
Clear Search sequence regions


  • antitumor (1)
  • cancers (1)
  • cell (3)
  • cellular (1)
  • e cadherin (2)
  • family (7)
  • gene (1)
  • humans (1)
  • kinases (2)
  • Lyn (8)
  • metastasis (4)
  • mice (1)
  • patient (1)
  • protein transport (1)
  • regulates (1)
  • rna (2)
  • snail (3)
  • src (2)
  • src- kinases (1)
  • vitro (1)
  • xenograft (1)
  • Sizes of these terms reflect their relevance to your search.

    The acquisition of an invasive phenotype by epithelial cells occurs through a loss of cellular adhesion and polarity, heralding a multistep process that leads to metastatic dissemination. Since its characterization in 1995, epithelial-mesenchymal transition (EMT) has been closely linked to the metastatic process. As a defining aspect of EMT, loss of cell adhesion through downregulation of E-cadherin is carried out by several transcriptional repressors; key among them the SNAI family of transcription factors. Here we identify for the first time that Lyn kinase functions as a key modulator of SNAI family protein localization and stability through control of the Vav-Rac1-PAK1 (Vav-Rac1-p21-activated kinase) pathway. Accordingly, targeting Lyn in vitro reduces EMT and in vivo reduces metastasis of primary tumors. We also demonstrate the clinical relevance of targeting Lyn as a key player controlling EMT; patient samples across many cancers revealed a strong negative correlation between Lyn and E-cadherin, and high Lyn expression in metastatic tumors as well as metastasis-prone primary tumors. This work reveals a novel pancancer mechanism of Lyn-dependent control of EMT and further underscores the role of this kinase in tumor progression.

    Citation

    D Thaper, S Vahid, K M Nip, I Moskalev, X Shan, S Frees, M E Roberts, K Ketola, K W Harder, C Gregory-Evans, J L Bishop, A Zoubeidi. Targeting Lyn regulates Snail family shuttling and inhibits metastasis. Oncogene. 2017 Jul 13;36(28):3964-3975

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 28288135

    View Full Text